213
Views
12
CrossRef citations to date
0
Altmetric
Original Research

The burden of suicidal ideation across Europe: a cross-sectional survey in five countries

, &
Pages 2257-2271 | Published online: 07 Aug 2019

References

  • Hardt J, Bernert S, Matschinger H, et al. Suicidality and its relationship with depression, alcohol disorders and childhood experiences of violence: results from the ESEMeD study. J Affect Disord. 2015;175:168–174. doi:10.1016/j.jad.2014.12.04425618003
  • Bernal M, Haro JM, Bernert S, et al. Risk factors for suicidality in Europe: results from the ESEMED study. J Affect Disord. 2007;101(1–3):27–34. doi:10.1016/j.jad.2006.09.01817074395
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: (5th ed.). Arlington, VA: American Psychiatric Association; 2013.
  • Vietri J, Montgomery W, Otsubo T, Tsuji T, Harada E. Association between pain severity, depression severity, and use of health care services in Japan: results of a nationwide survey. Neuropsychiatr Dis Treat. 2015;11:675–683. doi:10.2147/NDT.S7176825792837
  • Vos T, Allen C, Arora M, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1545–1602. doi:10.1016/S0140-6736(16)31678-627733282
  • World Health Organization (WHO). Depression and Other Common Mental Disorders Global Health Estimates. Geneva: World Health Organization;  2017.
  • Ferrari AJ, Somerville AJ, Baxter AJ, et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med. 2013;43(03):471–481. doi:10.1017/S003329171200151122831756
  • Alonso J, Angermeyer MC, Bernert S, et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand. 2004;109(s420):21–27. doi:10.1111/j.1600-0047.2004.00325.x
  • Isometsä E. Suicidal behaviour in mood disorders—who, when, and why? Can J Psychiatry. 2014;59(3):120–130. doi:10.1177/07067437140590030324881160
  • Nock MK, Borges G, Bromet EJ, et al. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry. 2008. doi:10.1192/bjp.bp.107.040113
  • Miret M, Caballero FF, Huerta-Ramírez R, et al. Factors associated with suicidal ideation and attempts in Spain for different age groups. Prevalence before and after the onset of the economic crisis. J Affect Disord. 2014;163:1–9. doi:10.1016/j.jad.2014.03.04524836081
  • Miret M, Ayuso-Mateos JL, Sanchez-Moreno J, Vieta E. Depressive disorders and suicide: epidemiology, risk factors, and burden. Neurosci Biobehav Rev. 2013;37(10):2372–2374. doi:10.1016/j.neubiorev.2013.01.00823313644
  • Pompili M, Venturini P, Lamis DA, et al. Suicide in stroke survivors: epidemiology and prevention. Drugs Aging. 2015;32(1):21–29. doi:10.1007/s40266-014-0233-x25491561
  • Woo JM, Jeon Hj, Noh E, et al.. Importance of remission and residual somatic symptoms in health-related quality of life among outpatients with major depressive disorder: a cross-sectional study. Health Qual Life Outcomes. 2014;12:188. doi:10.1186/s12955-014-0188-y25519704
  • Fairweather-Schmidt AK, Batterham PJ, Butterworth P, Nada-Raja S. The impact of suicidality on health-related quality of life: A latent growth curve analysis of community-based data. J Affect Disord. 2016;203:14–21. doi:10.1016/j.jad.2016.05.06727285722
  • Witt EA, Benson C, Shawi M, et al. Impact of Increasing levels of suicidal ideation among patients with depression impairment. Anxiety and Depression Association of America (ADAA) Annual Conference San Francisco, CA; 2017.
  • Woo J-M, Postolache TT. The impact of work environment on mood disorders and suicide: evidence and implications. Int J Disabil Hum Dev. 2008;7(2):185–200.18836547
  • Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64(12):1465–1475.14728109
  • Shepard DS, Gurewich D, Lwin AK, Reed GA, Silverman MM. Suicide and suicidal attempts in the united states: costs and policy implications. Suicide Life-Threatening Behav. 2016;46(3):352–362. doi:10.1111/sltb.12225
  • Siu AL, Bibbins-Domingo K, Grossman DC, et al. Screening for Depression in Adults. Jama. 2016;315(4):380. doi:10.1001/jama.2015.1839226813211
  • World Bank. Suicide mortality rate (per 100,000 population), 2016 Washington DC; World Bank, 2018.
  • Fond G, Llorca P-M, Boucekine M, et al. Disparities in suicide mortality trends between United States of America and 25 European countries: retrospective analysis of WHO mortality database. Sci Rep. 2016;6:20256. doi:10.1038/srep2025626883796
  • Hirschfeld RMA. The Mood disorder questionnaire: a simple, patient-rated screening instrument for bipolar disorder. Prim Care Companion J Clin Psychiatry. 2002;4(1):9–11.15014728
  • Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi:10.1046/j.1525-1497.2001.016009606.x11556941
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.3558716
  • Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42(9):851–859.15319610
  • Ware JEKM. How to Score Version 2 of the SF-12 HEALTH Survey. Lincoln, RI: Quality Metric Incorporated; 2002.
  • Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–1736. doi:10.1007/s11136-011-9903-x21479777
  • van Reenen M, Janssen B. EQ-5D-5L User Guide. Rotterdam: EuroQol Research Foundation; 2015.
  • Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–365. doi:10.2165/00019053-199304050-0000610146874
  • Serafini G, Pompili M, Innamorati M, et al. The impact of anxiety, depression, and suicidality on quality of life and functional status of patients with congestive heart failure and hypertension. Prim Care Companion J Clin Psychiatry. 2010;12(June2005):1–20.
  • Lutz J, Morton K, Turiano NA, Fiske A. Health conditions and passive suicidal ideation in the survey of health, ageing, and retirement in Europe. J Gerontol - Ser B Psychol Sci Soc Sci. 2016;71(5):936–946. doi:10.1093/geronb/gbw01927013533
  • Steptoe A, Wikman A, Molloy GJ, Kaski J-C. Anaemia and the development of depressive symptoms following acute coronary syndrome: longitudinal clinical observational study. BMJ Open. 2012;2(1):e000551. doi:10.1136/bmjopen-2011-000551
  • Ju YJ, Han K-T, Lee T-H, Kim W, Park JH, Park E-C. Association between weight control failure and suicidal ideation in overweight and obese adults: a cross-sectional study. BMC Public Health. 2016;16(1):259. doi:10.1186/s12889-016-2940-126975568
  • Poorolajal J, Darvishi N. Smoking and suicide: a meta-analysis. PLoS One. 2016;11(7):e0156348. doi:10.1371/journal.pone.015634827391330
  • Jonas JB, Nangia V, Rietschel M, Paul T, Behere P, Panda-Jonas S. Prevalence of depression, suicidal ideation, alcohol intake and nicotine consumption in rural central India. the central india eye and medical study. PLoS One. 2014;9:11. doi:10.1371/journal.pone.0113550
  • Kwak Y, Kim Y. Health-related quality of life and mental health of elderly by occupational status. Iran J Public Health. 2017;46(8):1028–1037.28894703
  • Saharinen T, Hintikka J, Niskanen L, et al. Health-related quality of life in a population-based sample of men with long-term mental symptoms. Nord J Psychiatry. 2008;62(2):106–112. doi:10.1080/0803948080196292118569773
  • Li H, Luo X, Ke X, et al. Major depressive disorder and suicide risk among adult outpatients at several general hospitals in a Chinese Han population. PLoS One. 2017;12(10):e0186143. doi:10.1371/journal.pone.018614329016669
  • Cocker F, Nicholson JM, Graves N, Oldenburg B, Palmer AJ. Depression in working adults: comparing the costs and health outcomes of working when ill. PLoS One. 2014;9(9):105430. doi:10.1371/journal.pone.0105430
  • Baj VS, Majo MC, Smit F, van Straten A, Kerkhof AJFM. Reducing suicidal ideation: cost-effectiveness analysis of a randomized controlled trial of unguided web-based self-help. J Med Internet Res. 2012;14(5):e141. doi:10.2196/jmir.196623103835
  • Ballard ED, Cwik M, Storr CL, Goldstein M, Eaton WW, Wilcox HC. Recent medical service utilization and health conditions associated with a history of suicide attempts. Gen Hosp Psychiatry. 2014;36(4):437–441. doi:10.1016/j.genhosppsych.2014.03.00424713329
  • Gauthier G, Guérin A, Zhdanava M, et al. Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis. BMC Psychiatry. 2017;17(1):222. doi:10.1186/s12888-017-1489-628629442
  • Barbato A, Vallarino M, Rapisarda F, Lora A, Caldas De Almeida M. EU-Compase for Action on Mental Health and Well-Being Access to Mental Health Care EUROPE. Utrecht: EU Compass Consortium; 2014.
  • World Health Organization (WHO). Integrating the Prevention, Treatment and Care of Mental Health Conditions and Other Noncommunicable Diseases within Health Systems. WHO European High-Level Conference on Noncommunicable Diseases. Copenhagen, WHO Regional Office for Europe: Ashgabat; 2019.
  • World Health Organization (WHO). WHO Regional Committee for Europe - 63rd Session; Çeşme Izmir: WHO Regional Office for Europe; 2013.
  • Serafini G, Pompili M, Belvederi Murri M, et al. The effects of repetitive transcranial magnetic stimulation on cognitive performance in treatment-resistant depression. A systematic review. Neuropsychobiology. 2015;71(3):125–139. doi:10.1159/00038135125925699
  • Girardi P, Pompili M, Innamorati M, et al. Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods. Hum Psychopharmacol Clin Exp. 2009;24(3):177–190. doi:10.1002/hup.1005
  • Pompili M, Serafini G, Innamorati M, et al. Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: A critical review. World J Biol Psychiatry. 2013;14(6):412–431. doi:10.3109/15622975.2013.76559323530731
  • Zou L, Yeung A, Li C, et al. Clinical medicine effects of meditative movements on major depressive disorder: a systematic review and meta-analysis of randomized controlled trials. J Clin Med. 2018. doi:10.3390/jcm7080195
  • Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Focus (Madison). 2018;16(4):420–429. doi:10.1176/appi.focus.16407
  • Oltedal L, Kessler U, Ersland L, et al. Effects of ECT in treatment of depression: study protocol for a prospective neuroradiological study of acute and longitudinal effects on brain structure and function. BMC Psychiatry. 2015;15:94. doi:10.1186/s12888-015-0477-y25927716